BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24293774)

  • 1. A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.
    Joffe H; Crawford S; Economou N; Kim S; Regan S; Hall JE; White D
    Sleep; 2013 Dec; 36(12):1977-85. PubMed ID: 24293774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women.
    Joffe H; Crawford SL; Freeman MP; White DP; Bianchi MT; Kim S; Economou N; Camuso J; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3847-3855. PubMed ID: 27680875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal Hot Flashes: Relationship to Objective Awakenings and Sleep Stage Transitions.
    Bianchi MT; Kim S; Galvan T; White DP; Joffe H
    J Clin Sleep Med; 2016 Jul; 12(7):1003-9. PubMed ID: 26951410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms.
    Joffe H; Soares CN; Thurston RC; White DP; Cohen LS; Hall JE
    Menopause; 2009; 16(4):671-9. PubMed ID: 19197217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia in women approaching menopause: Beyond perception.
    Baker FC; Willoughby AR; Sassoon SA; Colrain IM; de Zambotti M
    Psychoneuroendocrinology; 2015 Oct; 60():96-104. PubMed ID: 26142241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol.
    Joffe H; White DP; Crawford SL; McCurnin KE; Economou N; Connors S; Hall JE
    Menopause; 2013 Sep; 20(9):905-14. PubMed ID: 23481119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
    Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
    Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a pilot study of a cooling mattress pad to reduce vasomotor symptoms and improve sleep.
    Avis NE; Levine BJ; Coeytaux R
    Menopause; 2022 Aug; 29(8):973-978. PubMed ID: 35881974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index.
    Sowers MF; Zheng H; Kravitz HM; Matthews K; Bromberger JT; Gold EB; Owens J; Consens F; Hall M
    Sleep; 2008 Oct; 31(10):1339-49. PubMed ID: 18853931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing sleep across the menopausal transition.
    Baker FC
    Climacteric; 2023 Jun; 26(3):198-205. PubMed ID: 37011660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
    Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude of the impact of hot flashes on sleep in perimenopausal women.
    de Zambotti M; Colrain IM; Javitz HS; Baker FC
    Fertil Steril; 2014 Dec; 102(6):1708-15.e1. PubMed ID: 25256933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
    Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between vasomotor symptom frequency and weight gain in the Study of Women's Health Across the Nation.
    Gibson CJ; Shiozawa A; Epstein AJ; Han W; Mancuso S
    Menopause; 2023 Jul; 30(7):709-716. PubMed ID: 37314873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
    Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective sleep interruption and reproductive hormone dynamics in the menstrual cycle.
    Sharkey KM; Crawford SL; Kim S; Joffe H
    Sleep Med; 2014 Jun; 15(6):688-93. PubMed ID: 24841109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
    Shiozawa A; Thurston RC; Cook E; Yang H; King DD; Kristy RM; Mancuso S
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(10):1117-1128. PubMed ID: 37650213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot flashes and awakenings among midlife women.
    Thurston RC; Chang Y; Buysse DJ; Hall MH; Matthews KA
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31152182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women.
    Li J; Liu B; Tang R; Luo M; Li HJ; Peng Y; Wang Y; Liu G; Lin S; Chen R
    Climacteric; 2021 Apr; 24(2):151-156. PubMed ID: 33103941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Yoga and Aerobic Exercise on Actigraphic Sleep Parameters in Menopausal Women with Hot Flashes.
    Buchanan DT; Landis CA; Hohensee C; Guthrie KA; Otte JL; Paudel M; Anderson GL; Caan B; Freeman EW; Joffe H; LaCroix AZ; Newton KM; Reed SD; Ensrud KE
    J Clin Sleep Med; 2017 Jan; 13(1):11-18. PubMed ID: 27707450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.